Navigation Links
alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both

Research Indicates Being Overweight Increases Risk of Breast Cancer

PARSIPPANY, N.J., Sept. 22 /PRNewswire/ -- Who knew that simply putting on 21 - 30 pounds between your teens and your 50s could increase your risk of breast cancer after menopause? Now that word is getting out about the link between excess weight and breast cancer, women need support to not only lose those extra pounds and improve their health, but to also help deal with their emotions should they become one of the projected 182,460 American women diagnosed with breast cancer this year.

That's why alli(TM) and Breast Cancer Network of Strength(TM) are joining efforts to improve women's health with a limited edition pink package during National Breast Cancer Awareness Month in October. alli's 90-count package features a pink Shuttle (carrying case) along with special packaging highlighting Network of Strength's unique role in supporting breast cancer patients.

"alli is proud to support Breast Cancer Network of Strength which provides invaluable support to women during some very challenging times," said Karen Scollick, vice president Behavioral Science at GlaxoSmithKline Consumer Healthcare, the maker of alli. "Our partnership demonstrates our commitment to women's health and helps to ensure that women touched by breast cancer don't have to face it alone."

$150,000 Donation Supports YourShoes(TM)

Breast Cancer Network of Strength provides immediate emotional relief to anyone affected by breast cancer through the "YourShoes(TM)" 24/7 breast cancer support center, which includes the country's only toll-free hotline staffed exclusively by breast cancer survivors.

"When you've been diagnosed with breast cancer, you deal with so many emotions that you often aren't comfortable talking about with your husband, friends or even doctor," said Nancy Nixon, a breast cancer survivor who counsels callers through the YourShoes support center. "No one knows what you're going through like someone who has already been in your shoes. It's personally rewarding to help other women and let them know that they really can get through this, and we're here for them every step of the way."

Women Reduce Cancer Risk, Lose Weight with alli

More than four million Americans have lost weight with alli during the past year. Many of those success stories come from women like Cheryl Hartvigse from Columbia, S.C. who recognize that losing weight can improve their health and may reduce their breast cancer risk.

"Two of my family members have been diagnosed with breast cancer. As a pharmacist and hormone counselor, I know that obesity most definitely plays a role in breast cancer and that knowledge played a big part in my decision to lose 30 pounds," explained Hartvigse. "I've nearly reached my weight loss goal and alli's support system has really helped me lose the pounds. I feel 20 years younger and so much better about myself. Plus, I've reduced my risk of becoming another breast cancer statistic."

The special pink alli product is available at major retailers nationwide while supplies last. More information can be found at Breast cancer patients can talk to peer counselors at the YourShoes 24/7 support center by calling 1-800-221-2141. Interpreters are available in more than 150 languages.

About Breast Cancer Network of Strength

Breast Cancer Network of Strength(TM) provides immediate emotional relief to anyone affected by breast cancer through the "YourShoes(TM)" 24/7 breast cancer support center, which includes the country's only toll-free hotline staffed exclusively by breast cancer survivors. Learn more at

About alli

alli is the only FDA-approved weight-loss product available to overweight adults, 18 years or older, without a prescription. It combines a clinically-proven product with a comprehensive individualized action plan. The alli program encourages modest, gradual weight loss, known by experts as the best way to lose weight. alli (60 mg orlistat capsules) is safe and effective when used as directed.

About GlaxoSmithKline Consumer Healthcare

GSK Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne,(R) Tums(R) and Breathe Right(R).

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit:

Note: Breast Cancer Network of Strength name and emblem are used with its permission which in no way constitutes an endorsement, express or implied, of alli.

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
2. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
3. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
4. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
5. NIST and partners identify tiny gold clusters as top-notch catalysts
6. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
7. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
8. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
9. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
10. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
11. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):